SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Boyle Jack D.

(Last) (First) (Middle)
C/O ENDO INTERNATIONAL PLC
FIRST FL, MINERVA HOUSE, SIMMONSCOURT RD

(Street)
BALLSBRIDGE, DUBLIN L2

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/27/2019
3. Issuer Name and Ticker or Trading Symbol
Endo International plc [ ENDP ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Interim Controller
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares 16,239 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(1) 301 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(2) 1,458 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(3) 2,405 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(4) 20,616 D
2015 Stock Incentive Plan Restricted Stock Units (RSU)(5) 30,328 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
2015 Stock Incentive Plan Options (NQ)(6) (6) 02/19/2020 Ordinary Shares 1,418 20.61 D
2015 Stock Incentive Plan Options (NQ)(7) (7) 02/23/2021 Ordinary Shares 3,672 33.98 D
2015 Stock Incentive Plan Options (NQ)(8) (8) 02/22/2022 Ordinary Shares 4,175 34.7 D
2015 Stock Incentive Plan Options (NQ)(9) (9) 02/23/2026 Ordinary Shares 4,073 50.22 D
2015 Stock Incentive Plan Options (NQ)(10) (10) 05/26/2026 Ordinary Shares 7,912 15.22 D
2015 Stock Incentive Plan Options (NQ)(11) (11) 02/21/2027 Ordinary Shares 9,817 13.19 D
2015 Stock Incentive Plan Options (NQ)(12) (12) 08/10/2027 Ordinary Shares 16,400 7.55 D
Explanation of Responses:
1. On February 23, 2016, 1,207 RSUs were granted to Mr. Boyle with one-fourth vesting, and thus expiring, on each of the first four grant date anniversaries. As of September 27, 2019, 906 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date.
2. On February 21, 2017, 4,376 RSUs were granted to Mr. Boyle with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of September 27, 2019, 2,918 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date.
3. On August 10, 2017, 7,216 RSUs were granted to Mr. Boyle with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of September 27, 2019, 4,811 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date.
4. On April 2, 2018, 30,925 RSUs were granted to Mr. Boyle with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of September 27, 2019, 10,309 RSUs were vested and released. The amount reported in Table I represents the unvested portion as of that date.
5. On March 29, 2019, 30,328 RSUs were granted to Mr. Boyle with one-third vesting, and thus expiring, on each of the first three grant date anniversaries. As of September 27, 2019, no RSUs have vested or been released. The amount reported in Table I represents the unvested portion as of that date.
6. On February 19, 2010, 5,675 non-qualified stock options were granted to Mr. Boyle with one-fourth vesting on each of the first four grant date anniversaries. As of September 27, 2019, 5,675 non-qualified stock options had vested and 4,257 had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
7. On February 23, 2011, 3,672 non-qualified stock options were granted to Mr. Boyle with one-fourth vesting on each of the first four grant date anniversaries. As of September 27, 2019, 3,672 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
8. On February 22, 2012, 4,175 non-qualified stock options were granted to Mr. Boyle with one-fourth vesting on each of the first four grant date anniversaries. As of September 27, 2019, 4,175 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
9. On February 23, 2016, 4,073 non-qualified stock options were granted to Mr. Boyle with one-fourth vesting on each of the first four grant date anniversaries. As of September 27, 2019, 3,055 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
10. On May 26, 2016, 7,912 non-qualified stock options were granted to Mr. Boyle with one-third vesting on each of the first three grant date anniversaries. As of September 27, 2019, 7,912 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
11. On February 21, 2017, 9,817 non-qualified stock options were granted to Mr. Boyle with one-fourth vesting on each of the first four grant date anniversaries. As of September 27, 2019, 4,909 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
12. On August 10, 2017, 16,400 non-qualified stock options were granted to Mr. Boyle with one-third vesting on each of the first three grant date anniversaries. As of September 27, 2019, 10,934 non-qualified stock options had vested and none had been exercised. The amount reported in Table II represents the unexercised portion as of that date.
Remarks:
These securities represent the amounts owned by Mr. Boyle as of September 27, 2019, the date of effectiveness of his appointment as Senior Vice President, Interim Controller of Endo International plc.
/s/ Yoon Ah Oh, by power of attorney 10/03/2019
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
LIMITED POWER OF ATTORNEY FOR
SECTION 16 REPORTING OBLIGATIONS

    Know all by these present that the undersigned hereby makes, constitutes and appoints Matthew J. Maletta, Yoon Ah Oh, Justin Dailey and Sarah Beck as the undersigned's true and lawful attorneys-in-fact, with full power and authority as hereinafter described on behalf of and in the name, place and stead of each of the undersigned to:

(1)    prepare, execute, acknowledge, deliver and file Forms 3, 4, and 5 (including any amendments thereto) with respect to the securities of Endo International plc, an Irish public limited company (the "Company"), with the United States Securities and Exchange Commission, any national securities exchanges and the Company, as considered necessary or advisable under Section 16(a) of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as amended from time to time (the "Exchange Act");

(2)    seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such
 information to the undersigned and approves and ratifies any such release of information; and

(3)    perform any and all other acts which in the discretion of such attorney-in-fact are necessary or desirable for and on behalf of the undersigned in connection with the foregoing.

The undersigned acknowledges that:

(1)    this Power of Attorney authorizes, but does not require, such attorney-in-fact to act in their discretion on information provided to such attorney-in-fact without independent verification of such information;

(2)    any documents prepared and/or executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information and disclosure as such attorney-in-fact, in his or her discretion, deems necessary or desirable;

(3)    neither the Company nor such attorney-in-fact assumes (i) any liability for the undersigned's responsibility to comply with the requirement of the Exchange Act, (ii) any liability of the undersigned for any failure to comply with such requirements, or (iii) any obligation or liability of the undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and

(4)    this Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under the Exchange Act, including without limitation the reporting requirements under Section 16 of the Exchange Act.

The undersigned hereby gives and grants the foregoing attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary or appropriate to be done in and about the foregoing matters as fully to all intents and purposes as the undersigned might or could do if present, hereby ratifying all that such attorney-in-fact of, for and on behalf of the undersigned, shall lawfully do or cause to be done by virtue of this Limited Power of Attorney.

    This Power of Attorney shall remain in full force and effect with respect to each undersigned until revoked by such undersigned in a signed writing delivered to such attorney-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24 day of September 2019.

SIGNATURE                    TITLE
        
        
/S/ John D. Boyle                Senior Vice President, FP&A Finance and
NAME:  John D. Boyle                            Interim Controller and Chief Accounting Officer
                    


STATE OF Commonwealth of Pennsylvania:            
COUNTY OF Chester:
        

On this 24th day of September 2019, the above-named individual personally appeared before me, and acknowledged that he executed the foregoing instrument for the purposes therein contained.

IN WITNESS WHEREOF, I have hereunto set my hand and official seal.
                                          
      
/S/ Linda Jean Marchione
Notary Public

COMMONWEALTH OF PENNSYLVANIA
NOTARIAL SEAL
LINDA JEAN MARCHIONE
Notary Public
EAST WHITELAND TWP, CHESTER COUNTY
My Commission Expires Aug 9, 2020